Captor Therapeutics (CTX)
- Share price (7-session average)
- 69.25 PLN-4.42% w/w
- Market cap
- PLN 464.4M
- 52-week range
- 37.20 – 89.20 PLN
Prices as of October 2, 2026, delayed.
Last updated: Source: ESEF / ESPI / GPW
Price Chart
About Captor Therapeutics
Captor Therapeutics develops drugs based on targeted protein degradation technology. The most advanced project CT-01 is in a phase I clinical trial for hepatocellular carcinoma.
This description was generated with the help of AI and may contain inaccuracies. Please verify important information from official sources.
Company Details
Data sourced from GPW and OpenFIGI. Updated periodically — verify with official sources.
News
No news for CTX.
Communities
Frequently asked questions
- How much does a Captor Therapeutics share cost?
- The 7-day average share price of Captor Therapeutics (CTX) on GPW is 69.25 PLN.
- On which exchange is Captor Therapeutics listed?
- Captor Therapeutics is listed on GPW under the ticker CTX, ISIN: PLCPTRT00014.
- Is Captor Therapeutics stock being shorted?
- Per the KNF short-selling register (as of October 4, 2026), there are no disclosed net short positions in Captor Therapeutics. KNF discloses positions from 0.5% of share capital, so smaller ones are not visible.
Similar companies — Biotechnology
Explore the market
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.